![Katherine R. McCurdy](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Katherine R. McCurdy
Fundador en The Barth Syndrome Foundation, Inc. .
Perfil
Katherine R.
McCurdy is the founder of The Barth Syndrome Foundation, Inc. where she currently holds the titles of Chairman and Chairman-Scientific & Medical Advisory.
The company was founded in 2000.
Cargos activos de Katherine R. McCurdy
Empresas | Cargo | Inicio |
---|---|---|
The Barth Syndrome Foundation, Inc.
![]() The Barth Syndrome Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services The Barth Syndrome Foundation, Inc. is a non-profit organization that focuses on Barth Syndrome, an ultra-rare genetic condition that primarily affects males. The private company is based in Larchmont, NY and was founded in 2000 by Katherine R. McCurdy. The condition is characterized by cardiac abnormalities, exercise intolerance, muscle weakness, severe fatigue, recurrent infections, and delayed growth. The foundation aims to raise awareness about the condition and fund research to find a cure. There are currently no FDA- or EMA-approved therapies for patients with Barth Syndrome. | Fundador | 01/01/2000 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 1 |
---|---|
The Barth Syndrome Foundation, Inc.
![]() The Barth Syndrome Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services The Barth Syndrome Foundation, Inc. is a non-profit organization that focuses on Barth Syndrome, an ultra-rare genetic condition that primarily affects males. The private company is based in Larchmont, NY and was founded in 2000 by Katherine R. McCurdy. The condition is characterized by cardiac abnormalities, exercise intolerance, muscle weakness, severe fatigue, recurrent infections, and delayed growth. The foundation aims to raise awareness about the condition and fund research to find a cure. There are currently no FDA- or EMA-approved therapies for patients with Barth Syndrome. | Commercial Services |
- Bolsa de valores
- Insiders
- Katherine R. McCurdy